Konkurrenz
| Unternehmen | Börsenwert | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|
|
Eli Lilly and NYSE:LLY |
854,12 Mrd. | 23,56 % | 6/6 | 34,75 % | 13,05 % | 32,00 % | DOWN |
|
Johnson & Johnson NYSE:JNJ |
587,99 Mrd. | 5,27 % | 5/5 | 6,91 % | -33,67 % | 0,36 % | UP |
|
Merck NYSE:MRK |
298,76 Mrd. | 7,67 % | 6/6 | -21,36 % | -11,04 % | 9,24 % | UP |
|
Pfizer NYSE:PFE |
162,40 Mrd. | 7,82 % | 4/6 | -5,31 % | 17,48 % | -5,43 % | UP |
|
Bristol-Myers Squibb NYSE:BMY |
126,04 Mrd. | 1,77 % | 5/6 | -0,30 % | -6,12 % | 3,68 % | UP |
|
Vertex Pharmaceuticals NasdaqGS:VRTX |
113,62 Mrd. | 13,44 % | 6/6 | 6,43 % | -3,67 % | 24,76 % | DOWN |
|
Regeneron Pharmaceuticals NasdaqGS:REGN |
79,76 Mrd. | 9,26 % | 5/6 | 5,41 % | 1,05 % | 12,58 % | UP |
|
Zoetis NYSE:ZTS |
49,51 Mrd. | 9,80 % | 6/6 | 7,18 % | 47,42 % | 23,63 % | DOWN |
|
United Therapeutics NasdaqGS:UTHR |
25,00 Mrd. | 15,13 % | 5/6 | 2,41 % | -42,62 % | 13,36 % | UP |
|
Viatris NasdaqGS:VTRS |
15,69 Mrd. | -3,69 % | 4/6 | 2,85 % | -38,28 % | 24,72 % | UP |
|
Madrigal Pharmaceuticals NasdaqGS:MDGL |
12,16 Mrd. | 0,00 % | 2/4 | 0,00 % | 0,00 % | 21,17 % | UP |
|
Catalent NYSE:CTLT |
11,52 Mrd. | -5,82 % | 2/6 | 27,69 % | -22,42 % | 0,03 % | UP |
|
Cytokinetics NasdaqGS:CYTK |
8,20 Mrd. | -1,08 % | 1/6 | 4,92 % | -45,52 % | 35,11 % | UP |
|
TG Therapeutics NasdaqCM:TGTX |
4,96 Mrd. | 63,45 % | 3/5 | 33,54 % | 93,04 % | 36,99 % | UP |
|
Indivior Pharmaceuticals NasdaqGS:INDV |
3,72 Mrd. | 28,91 % | 5/6 | 13,62 % | -0,04 % | 18,24 % | UP |
|
Corcept Therapeutics NasdaqCM:CORT |
4,47 Mrd. | 10,36 % | 5/6 | 118,76 % | 15,72 % | 42,93 % | DOWN |
|
Ligand Pharmaceuticals NasdaqGM:LGND |
3,98 Mrd. | 7,83 % | 5/6 | 3,60 % | -47,52 % | 20,98 % | UP |
|
Supernus Pharmaceuticals NasdaqGM:SUPN |
2,96 Mrd. | 2,48 % | 3/6 | 8,61 % | -31,76 % | 26,36 % | UP |
|
Endo OTCPK:NDOI |
1,80 Mrd. | 3,65 % | 0/5 | 61,08 % | 23,81 % | -100,00 % | DOWN |
|
Nektar Therapeutics NasdaqCM:NKTR |
2,17 Mrd. | 65,15 % | 4/6 | 74,02 % | -466,81 % | 73,69 % | UP |

































